Early detection of cancer return after rectal or esophageal surgery
Part of Cancer, Digestive system clinical trials.
This study uses artificial intelligence to look for tiny signs of cancer left behind after treatment, which could help catch a return of the disease earlier. It involves giving blood samples over 6 months and possibly sharing a sample of your tumor tissue.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with rectal or esophageal cancer.
- Your treatment plan includes surgery to remove the cancer, and you are receiving standard treatment before or around the time of surgery.
- You are willing to give blood samples at three time points: before treatment, 3 months after treatment, and 6 months after treatment.
- You agree to let researchers use your blood and medical information for this study.
- You may also be asked to provide a sample of your tumor tissue (from a previous biopsy or surgery) if available.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an AI system that helps identify cancer or polyp findings during rectal surgery or assessment, using real-time information. It may help surgeons classify tissue more accurately while you are already getting treatment.
This study looks at patterns in the gut microbiome (gut bacteria) and gut chemicals (metabolites) to predict how rectal cancer may do after planned surgery. By understanding these markers, researchers hope to better forecast prognosis and tailor follow-up.
This study looks at whether a blood test that finds tumor DNA can help doctors choose the best treatment for rectal cancer, possibly allowing some patients to avoid surgery. It tests different chemotherapy and radiation combinations to see if the cancer disappears completely.
This study tests if a simple blood test can detect early signs of colorectal cancer coming back after surgery to remove cancer spread in the abdomen. It may help patients avoid unnecessary treatments and catch recurrence sooner.
This study is looking at whether regular checks of your blood for tiny pieces of cancer DNA (called MRD) can help doctors monitor for the cancer coming back after surgery. It plans to use this information to guide follow-up care.
This study looks for tiny traces of cancer left in the body after treatment and surgery. It may help doctors understand if the cancer could come back, so it can be caught and treated earlier.
Hear when a new Rectal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.